Literature DB >> 3873008

Evidence for two subtypes of Cushing's disease based on the analysis of episodic cortisol secretion.

E Van Cauter, S Refetoff.   

Abstract

To investigate the pathogenetic mechanisms of Cushing's syndrome, we studied variations in plasma cortisol levels (episodic variations, or pulses) over 24 hours in 51 normal subjects, 14 patients with adrenal adenoma, and 46 patients with Cushing's disease. Data were obtained both from our patients and from the literature. As compared with normal subjects, patients with adrenal adenoma had fewer spikes in cortisol levels (defined as an elevation of at least 10 per cent and no less than 1 microgram per deciliter), and the spikes were lower both in absolute terms (4.0 +/- 1.8 vs. 5.1 +/- 2.2 micrograms per deciliter, P less than 0.05) and in terms of the percentage of the preceding trough concentration (23 +/- 7 vs. 123 +/- 74 per cent, P less than 0.001). Patients with Cushing's disease seemed to fall into two groups: those with hypopulsatile and those with hyperpulsatile secretion. The hypopulsatile group had a normal number and absolute height of spikes, but their height relative to the preceding trough concentration was lower than in controls (42 +/- 16 vs. 123 +/- 74 per cent, P less than 0.005). In contrast, the hyperpulsatile group had a similar number of spikes as the hypopulsatile group, but their absolute and relative heights were twice as great (12.7 +/- 2.3 vs. 6.0 +/- 1.6 micrograms per deciliter and 84 +/- 40 vs. 42 +/- 16 per cent, respectively; P less than 0.001 for both). We hypothesize that the Cushing's disease in the second group of patients may have been caused by increased hypothalamic release of, or pituitary responsiveness to, corticotropin-releasing factor, whereas that in the first group may represent pituitary oversecretion of corticotropin that is relatively independent of corticotropin-releasing factor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3873008     DOI: 10.1056/NEJM198505233122102

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  19 in total

1.  Circadian variation in Cushing's disease and pseudo-Cushing states by analysis of F and ACTH pulsatility.

Authors:  J M Cunningham; O M Buxton; R E Weiss
Journal:  J Endocrinol Invest       Date:  2002-10       Impact factor: 4.256

2.  Cyclical Cushing's disease and its successful control under sodium valproate.

Authors:  A Beckers; A Stevenaert; G Pirens; P Flandroy; J Sulon; G Hennen
Journal:  J Endocrinol Invest       Date:  1990-12       Impact factor: 4.256

3.  Diagnosis and treatment of Cushing's syndrome. Cushing's syndrome: current clinical problems, symposium. Padova, October 19-20, 1990.

Authors: 
Journal:  J Endocrinol Invest       Date:  1992-03       Impact factor: 4.256

4.  Endogenous ACTH concentration-cortisol secretion dose analysis unmasks decreased ACTH potency in Cushing's disease with restoration after successful pituitary adenomectomy.

Authors:  Ferdinand Roelfsema; Daniel M Keenan; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2011-09-14       Impact factor: 5.958

5.  Pulsatile secretion of parathyroid hormone and its action on a type I and type II PTH receptor: a hypothesis for understanding osteoporosis.

Authors:  R D Hesch; G Brabant; E F Rittinghaus; M J Atkinson; H Harms
Journal:  Calcif Tissue Int       Date:  1988-06       Impact factor: 4.333

6.  The rise in cortisol in family day care: associations with aspects of care quality, child behavior, and child sex.

Authors:  Megan R Gunnar; Erin Kryzer; Mark J Van Ryzin; Deborah A Phillips
Journal:  Child Dev       Date:  2010 May-Jun

7.  Differential brain activity as a function of social evaluative stress in early adolescence: Brain function and salivary cortisol.

Authors:  Max P Herzberg; Ruskin H Hunt; Kathleen M Thomas; Megan R Gunnar
Journal:  Dev Psychopathol       Date:  2020-12

Review 8.  Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia.

Authors:  Hershel Raff; Susmeeta T Sharma; Lynnette K Nieman
Journal:  Compr Physiol       Date:  2014-04       Impact factor: 9.090

9.  Effect of the serotonin antagonists ritanserin and ketanserin in Cushing's disease.

Authors:  N Sonino; G A Fava; F Fallo; A Franceschetto; P Belluardo; M Boscaro
Journal:  Pituitary       Date:  2000-10       Impact factor: 4.107

10.  A time to be stressed? Time perspectives and cortisol dynamics among healthy adults.

Authors:  Lening A Olivera-Figueroa; Robert-Paul Juster; Julie Katia Morin-Major; Marie-France Marin; Sonia J Lupien
Journal:  Biol Psychol       Date:  2015-09-08       Impact factor: 3.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.